Author

Ke-Liang Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Safety profile and potential favorable reporting signals of liraglutide in patients with ulcerative colitis: A FAERS pharmacovigilance and network pharmacology study

Abstract: Background: Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has preclinical anti-inflammatory and barrier-protective effects, but its safety profile and potential favorable reporting associations in ulcerative colitis (UC) remain uncertain. Objectives: To characterize liraglutide-associate...

Ke-Liang Liu · Pakistan Journal of Pharmace... · 0 citations

Review Open access Sep 2026

Congenital hepatic fibrosis and related ciliopathies across the life course: current management, disease burden, and unmet needs in the era of genomic diagnosis and translational therapeutics

This review systematically evaluates the associated disease burden and critically appraises the limitations of current diagnostic and treatment paradigms, as well as the unmet needs in clinical practice to provide critical insights and a theoretical framework to inform future research directions, optimise therapeutic r...

Ao Wang, Jie He, Ke-Liang Liu et al. · Frontiers in Pediatrics · 0 citations